Author Correction: Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling.

Autor: Danussi C; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Bose P; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Parthasarathy PT; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Silberman PC; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Van Arnam JS; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Vitucci M; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, 27516, USA., Tang OY; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Heguy A; Department of Pathology, New York University School of Medicine, New York, NY, 10016, USA., Wang Y; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Chan TA; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA.; Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, 10065, USA., Riggins GJ; Departments of Neurosurgery, Oncology, and Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD, 21231, USA., Sulman EP; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Lang FF; Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA., Creighton CJ; Department of Medicine and Dan L. Duncan Comprehensive Cancer Center Division of Biostatistics, Baylor College of Medicine, Houston, TX, 77030, USA., Deneen B; Department of Neuroscience, Baylor College of Medicine, Houston, TX, 77030, USA., Miller CR; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, 27516, USA.; Departments of Pharmacology and Neurology, Lineberger Comprehensive Cancer Center and Neuroscience Center, University of North Carolina School of Medicine, Chapel Hill, NC, 27516, USA., Picketts DJ; Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, ON, K1H 8L6, Canada.; Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada., Kannan K; Department of Pathology, New York University School of Medicine, New York, NY, 10016, USA., Huse JT; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jhuse@mdanderson.org.; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. jhuse@mdanderson.org.
Jazyk: angličtina
Zdroj: Nature communications [Nat Commun] 2022 Jan 05; Vol. 13 (1), pp. 190. Date of Electronic Publication: 2022 Jan 05.
DOI: 10.1038/s41467-021-27820-5
Databáze: MEDLINE